News for 9 Meters Biopharma, Inc. (NMTR)

Humacyte has promising potential with FDA designations and a pending FDA approval decision for its ATEV product. Learn more about HUMA stock here.

NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Nymox Pharmaceutical Corporation. Nymox Pharmaceutical Corporation's securities were

ROCKVILLE, Md., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.08%

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.06%

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 300 points on Tuesday. The Dow traded up 1% to 34,932.08 while the NASDAQ rose 0.34% to 14,293.55. The S&P 500, also rose, gaining, 0.46% to 4,543.70.

U.S. stocks traded mixed this morning, with the Dow Jones gaining around 70 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.20% to 34,655.10 while the NASDAQ fell 0.38% to 14,190.20. The S&P 500, also fell, declining, 0.05% to 4,520.47.

9 Meters Biopharma (NMTR) lost ~16% on Tuesday after announcing the immediate resignation of its President and Chief Executive Officer John Temperato. Read more here.

9 Meters Biopharma press release (NMTR): Q4 GAAP EPS of -$0.92 misses by $0.12.As of December 31, 2022, the Company had total cash and cash equivalents of approximately $29.7...

According to Fortune Business Insights, Short Bowel Syndrome Market to Reach USD 2,213.5 million by 2029; Rising Awareness of Rare Diseases and the Growing...

Read Brookline Capital Management Reaffirms Buy Rating for 9 Meters Biopharma (NASDAQ:NMTR) at ETF Daily News

Read 9 Meters Biopharma (NASDAQ:NMTR) Reaches New 12-Month High at $3.65 at ETF Daily News

Read 9 Meters Biopharma’s (NMTR) “Buy” Rating Reaffirmed at Brookline Capital Management at ETF Daily News

On Monday morning, 66 companies achieved new lows for the year. Noteable 52-Week Lows: Gilead Sciences (NASDAQ:GILD) was the largest firm on a market ...

In this article we are going to use hedge fund sentiment as a tool and determine whether Matrix Service Co (NASDAQ:MTRX) is a good investment right now.

We at Insider Monkey have gone over 866 13F filings that hedge funds and prominent investors are required to file by the SEC. The 13F filings show the...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 16) 10X ...

Are These 4 Penny Stocks On Your Watch List? As we approach the halfway point of February, a lot is going on globally, affecting penny stocks. Before we get in...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 11) 10X ...